Top Markets
#1 Geodnet Geodnet +29.44%
#2 XPIN Network XPIN Network +28.39%
#3 Ore Ore +23.60%
#4 EXOD EXOD +22.08%
#5 AUKI AUKI +21.42%
#6 The Black Bull The Black Bull +21.41%
#7 Verus Coin Verus Coin +20.47%
#8 Arowana Arowana +20.04%
#9 SSV Network SSV Network +17.92%
#10 Ethena Staked ENA Ethena Staked ENA +16.65%
Coin of the day
Geodnet Geodnet
설정
언어
한국어
통화
USD
테마
Cortexyme, Inc. Cortexyme, Inc.

Cortexyme, Inc.

CRTX
주식 순위 #25185
Cortexyme, Inc. is a clinical-stage biopharmaceutical firm committed to... Cortexyme, Inc. is a clinical-stage biopharmaceutical firm committed to pioneering new therapies for Alzheimer's and various other degenerative conditions. The company's primary investigational drug, atuzaginstat (also known as COR388), is an orally delivered, small molecule inhibitor engineered to cross the blood-brain barrier and target gingipain. This compound is currently in Phase II/III clinical trials, where it is being assessed for its potential use in individuals with mild to moderate Alzheimer's disease, as well as for tackling oral squamous cell carcinoma, periodontitis, and coronavirus infections. Established in 2012, Cortexyme, Inc. is headquartered in South San Francisco, California.
주가
$1.95
마지막 동기화: 2022-07-29
시가총액
$52.48M
변동 (1일)
2.63%
변동 (1년)
0.00%
국가
US
거래 Cortexyme, Inc. (CRTX)

카테고리

Healthcare
Cortexyme, Inc. (CRTX)의 주가 이력
최고 종가: $2.18 (2022-07-01 기준)

최저 종가: $26.37 (2019-05-01 기준)
Cortexyme, Inc.의 주가 이력 (2019 ~ 2026)
연간 주가 성과
연도 성과
2022 -82.87%
2021 -62.60%
2020 -23.16%
2019 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $539.14 35.65%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 56.21%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -18.24%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $760.57 8.46%
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $130.43 397.46%
US